Search
Toggle theme
Menu
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients | NobleBlocks
Back
Home
Publications
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
Public
More options
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
N
Shared by
NobleBlocks
on Nov 19, 2008 • 12:00 AM UTC
Authors:
Shobha Rani Nalluri
,
David Chu
,
Roger Keresztes
+2 more
Download PDF
Share
Summary
Sum
PDF
Figures
Figs
Discrepancies
Disc
EDDII
Article
Art
Finding related papers...
Discussions
(0)
Add Comment
No comments yet
Be the first to share your thoughts!
